[1]
L. Mastorino, “Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy”, Acta Derm Venereol, vol. 102, p. adv00821, Nov. 2022.